Francesco Maria Lavino
Amministratore Delegato presso F2G Ltd.
Posizioni attive di Francesco Maria Lavino
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
F2G Ltd.
 F2G Ltd. Pharmaceuticals: MajorHealth Technology F2G Ltd. provides novel drugs for the treatment of life-threatening systemic fungal diseases. It primarily focuses on developing an F3 series of anti mould compound, which is an antifungal agent that acts through a mechanism different from marketed drugs. The company was founded in 1998 and is headquartered in Manchester, the United Kingdom. | Direttore/Membro del Consiglio | 12/04/2021 | - |
| Amministratore Delegato | 12/04/2021 | - | |
| F2g Inc. | Direttore/Membro del Consiglio | - | - |
| Presidente | - | - |
Storia della carriera di Francesco Maria Lavino
Precedenti posizioni note di Francesco Maria Lavino
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| MERCK & CO., INC. | Corporate Officer/Principal | 01/09/2015 | 01/07/2017 |
| CUBIST PHARMACEUTICALS INC | Vendite & Marketing | 01/12/2013 | 01/09/2015 |
| MERCK & CO., INC. | Direttore/Membro del Consiglio | 01/01/2011 | 01/11/2013 |
| NABRIVA THERAPEUTICS PLC | Corporate Officer/Principal | 10/07/2017 | - |
Formazione di Francesco Maria Lavino
| Università degli Studi di Napoli Federico II | Undergraduate Degree |
| SDA Bocconi School of Management | Masters Business Admin |
Statistiche
Distribuzione geografica
| Stati Uniti | 4 |
| Italia | 3 |
| Irlanda | 2 |
Posizioni
| Director/Board Member | 3 |
| Corporate Officer/Principal | 2 |
| Sales & Marketing | 1 |
Settori
| Health Technology | 5 |
| Consumer Services | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| NABRIVA THERAPEUTICS PLC | Health Technology |
| MERCK & CO., INC. | Health Technology |
| Aziende private | 3 |
|---|---|
Cubist Pharmaceuticals LLC
 Cubist Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Cubist Pharmaceuticals LLC operates as a biopharmaceutical company. It focuses on the research, development and commercialization of pharmaceutical products. The company was founded in 1992 and is headquartered in Lexington, MA. | Health Technology |
F2G Ltd.
F2G Ltd. Pharmaceuticals: MajorHealth Technology F2G Ltd. provides novel drugs for the treatment of life-threatening systemic fungal diseases. It primarily focuses on developing an F3 series of anti mould compound, which is an antifungal agent that acts through a mechanism different from marketed drugs. The company was founded in 1998 and is headquartered in Manchester, the United Kingdom. | Health Technology |
| F2g Inc. |
